Android向けのRheumatoid Arthritis - DAS28, SDAI, CDAI, ACR APKをダウンロードしましょう
Frontiers | Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations
Mean CDAI score and PROs at the 12-month follow-up | Download Scientific Diagram
Crohn's Disease Clinical Trial | Entyvio® (vedolizumab)
Short CDAI: Development and validation of a shortened and simplified Crohn's disease activity index | Semantic Scholar
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial - The Lancet
Crohn's Disease Activity Index (CDAI) | Download Table
Outcomes of long-term maintenance infliximab therapy in adult patients with moderate to severe Crohn's disease from March 2003 to December 2010 – 3/2012 – Ročník 2012 – Archiv ročníků – Remedia – farmakoterapeutický časopis
Galen eCalcs - Calculator: Rheumatoid Arthritis Clinical Disease Activity Index - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki
Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease | Scientific Reports
REVIEWER WORKSHEETS - Ustekinumab (Stelara) - NCBI Bookshelf
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease | NEJM Evidence
CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice | Annals of the Rheumatic Diseases
Applied Sciences | Free Full-Text | Rheumatoid Arthritis Diagnosis: Deep Learning vs. Humane | HTML
Entyvio - NPS MedicineWise
Rheumatoid arthritis disease activity index-5: Utility in busy clinical settings Singh H, Tanwar VS, Sukhija G, Mathur R, Kaur P - Indian J Rheumatol
A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn's Disease | PLOS ONE
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity - Khanna - 2015 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
HUMIRA® (adalimumab) for Crohn's Disease in adults
CDAI by Softwebo Sp. z o. o.
The Lancet Gastroenterology & Hepatology on Twitter: "Bruce Sands presents results from the head-to-head SEAVUE randomised trial of ustekinumab vs adalimumab for induction and maintenance in moderate-to-severe #Crohns disease #DDW2021 #gitwitter #IBD
Galen eCalcs - Calculator: Crohn's Activity Index - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity - Khanna - 2015 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
AB0119 DISCORDANCE OF RAPID3 AND CDAI IN RHEUMATOID ARTHRITIS | Annals of the Rheumatic Diseases
Disease Activity Monitoring in Rheumatoid Arthritis in Daily Practice: Experiences with METEOR, a Free Online Tool | The Journal of Rheumatology
Moderately to severely active Crohn's disease | CIMZIA® (certolizumab pegol)
